UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 256

Sortiert nach

Spezifische Immuntherapie--Erfahrungen in der Onkologie

Drug research, 2015-11, Vol.65 Suppl 1, p.S21

Gramatzki, M

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension

Journal of internal medicine, 2019-07, Vol.286 (1), p.63-74

2019

Link zum Volltext

Verfügbarkeit prüfen

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia

Leukemia, 2013-06, Vol.27 (6), p.1254-1262

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.614-621

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.552-560

2017

Link zum Volltext

Verfügbarkeit prüfen

Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients

Bone marrow transplantation (Basingstoke), 2008-08, Vol.42 (4), p.275-279

2008

Link zum Volltext

Verfügbarkeit prüfen

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

Leukemia, 2017-06, Vol.31 (6), p.1463-1466

2017

Link zum Volltext

Verfügbarkeit prüfen

The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients

Leukemia, 2013-07, Vol.27 (7), p.1595-1598

2013

Link zum Volltext

Verfügbarkeit prüfen

CD20‐Specific Immunoligands Engaging NKG2D Enhance γδ T Cell‐Mediated Lysis of Lymphoma Cells

Scandinavian journal of immunology, 2017-10, Vol.86 (4), p.196-206

2017

Link zum Volltext

Verfügbarkeit prüfen

The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells

Leukemia, 2013-01, Vol.27 (1), p.190-201

2013

Link zum Volltext

Verfügbarkeit prüfen

Dental status does not predict infection during stem cell transplantation: a single-center survey

Bone marrow transplantation (Basingstoke), 2017-07, Vol.52 (7), p.1041-1043

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.143-147

2011

Link zum Volltext

Verfügbarkeit prüfen

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

Annals of oncology, 2004-11, Vol.15 (11), p.1691-1698

2004

Link zum Volltext

Verfügbarkeit prüfen

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity

Leukemia, 2012-04, Vol.26 (4), p.830-834

2012

Link zum Volltext

Verfügbarkeit prüfen

The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells

Blood cancer journal (New York), 2014-06, Vol.4 (6), p.e219-e219

2014

Link zum Volltext

Verfügbarkeit prüfen

A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e221-e221

2015

Link zum Volltext

Verfügbarkeit prüfen

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

Haematologica (Roma), 2018-02, Vol.103 (2), p.197

2018

Link zum Volltext

Verfügbarkeit prüfen

P10.19.B An immunotoxin targeting CD317 for the treatment of glioblastoma

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii53-ii53

2022

Link zum Volltext

Verfügbarkeit prüfen

Pretherapeutic identification of high‐risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters

Cytometry. Part B, Clinical cytometry, 2003-05, Vol.53B (1), p.4-10

2003

Link zum Volltext

Verfügbarkeit prüfen

IL-2 in combination with IFN-α and 5-FU versus tamoxifen in metastatic renal cell carcinoma : long-term results of a controlled randomized clinical trial

British journal of cancer, 2001-10, Vol.85 (8), p.1130-1136

2001

Link zum Volltext

Verfügbarkeit prüfen

Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells

Blood, 1998-03, Vol.91 (6), p.1858-1863

1998

Link zum Volltext

Verfügbarkeit prüfen

A phase I/IIa study of the human CD38 antibody MOR202 (MOR03087) in relapsed or refractory multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e80-e80

2015

Link zum Volltext

Verfügbarkeit prüfen

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

The Journal of immunology (1950), 2000-11, Vol.165 (10), p.5954-5961

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(222)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(132)
Science & Technology
(122)
Life Sciences & Biomedicine
(121)
Biological And Medical Sciences
(70)
Female
(69)
Male
(65)
Medical Sciences
(63)
Hematology
(61)
Adult
(60)
Oncology
(58)
Middle Aged
(53)
Aged
(38)
Immunology
(30)
Animals
(24)
Hematologic And Hematopoietic Diseases
(23)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(23)
Treatment Outcome
(22)
Transplantation
(21)
Tumor Cells, Cultured
(21)
Pharmacology. Drug Treatments
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(28)
Neuro-Oncology
(18)
Journal Of Clinical Oncology
(17)
Bone Marrow Transplantation
(13)
Leukemia
(13)
Biology Of Blood And Marrow Transplantation
(11)
British Journal Of Haematology
(9)
European Journal Of Cancer
(8)
Cancer Research
(6)
Haematologica
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spezifische Immuntherapie--Erfahrungen in der Onkologie

Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult patients

CD20‐Specific Immunoligands Engaging NKG2D Enhance γδ T Cell‐Mediated Lysis of Lymphoma Cells

The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells

Dental status does not predict infection during stem cell transplantation: a single-center survey

Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity

The novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells

A novel human Fc-optimized ICAM-1/CD54 antibody (MSH-TP15e) with potent anti-myeloma activity in vitro and in vivo

From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

P10.19.B An immunotoxin targeting CD317 for the treatment of glioblastoma

Pretherapeutic identification of high‐risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma

IL-2 in combination with IFN-α and 5-FU versus tamoxifen in metastatic renal cell carcinoma : long-term results of a controlled randomized clinical trial

Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells

A phase I/IIa study of the human CD38 antibody MOR202 (MOR03087) in relapsed or refractory multiple myeloma

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

Suchergebnisse filtern